Mary E. Klein

723 total citations · 1 hit paper
8 papers, 499 citations indexed

About

Mary E. Klein is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mary E. Klein has authored 8 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Genetics. Recurrent topics in Mary E. Klein's work include Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mary E. Klein is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mary E. Klein collaborates with scholars based in United States. Mary E. Klein's co-authors include Andrew Koff, William D. Tap, Marta Kovatcheva, Lara E. Davis, Aimeé M. Crago, Mark A. Dickson, Samuel Singer, Gary K. Schwartz, Rachael O’Connor and Nicholas D. Socci and has published in prestigious journals such as Nature Communications, Blood and Cancer Cell.

In The Last Decade

Mary E. Klein

7 papers receiving 497 citations

Hit Papers

CDK4/6 Inhibitors: The Mechanism of Action May Not Be as ... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Klein United States 6 295 275 174 84 63 8 499
Rebecca Watters United States 12 217 0.7× 211 0.8× 232 1.3× 53 0.6× 16 0.3× 25 519
Kimberly B. Monahan United States 5 174 0.6× 90 0.3× 172 1.0× 24 0.3× 15 0.2× 6 324
Jacqueline A. Brosnan‐Cashman United States 13 368 1.2× 84 0.3× 277 1.6× 88 1.0× 85 1.3× 29 667
Leila Dardaei United States 10 283 1.0× 349 1.3× 333 1.9× 30 0.4× 11 0.2× 13 627
Silvia Vonlanthen Switzerland 8 288 1.0× 119 0.4× 428 2.5× 24 0.3× 18 0.3× 11 563
Susan M. Kitchen-Goosen United States 12 125 0.4× 153 0.6× 230 1.3× 17 0.2× 24 0.4× 18 466
W. Brugger Germany 9 207 0.7× 93 0.3× 101 0.6× 72 0.9× 20 0.3× 18 463
Laura López-Vicente Spain 4 166 0.6× 66 0.2× 265 1.5× 17 0.2× 42 0.7× 4 480
Camino Menéndez Spain 8 226 0.8× 95 0.3× 146 0.8× 20 0.2× 20 0.3× 11 355
Curt J. Essenburg United States 9 149 0.5× 106 0.4× 180 1.0× 40 0.5× 7 0.1× 17 413

Countries citing papers authored by Mary E. Klein

Since Specialization
Citations

This map shows the geographic impact of Mary E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Klein more than expected).

Fields of papers citing papers by Mary E. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Klein. The network helps show where Mary E. Klein may publish in the future.

Co-authorship network of co-authors of Mary E. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Klein. A scholar is included among the top collaborators of Mary E. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Klein. Mary E. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Klein, Mary E., Mark A. Dickson, Cristina R. Antonescu, et al.. (2018). PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. 37(37). 5066–5078. 35 indexed citations
2.
Klein, Mary E., Marta Kovatcheva, Lara E. Davis, William D. Tap, & Andrew Koff. (2018). CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought. Cancer Cell. 34(1). 9–20. 274 indexed citations breakdown →
3.
Kovatcheva, Marta, Will Liao, Mary E. Klein, et al.. (2017). ATRX is a regulator of therapy induced senescence in human cells. Nature Communications. 8(1). 386–386. 62 indexed citations
4.
Kovatcheva, Marta, Mary E. Klein, William D. Tap, & Andrew Koff. (2017). Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.. Molecular & Cellular Oncology. 5(1). e1384882–e1384882. 5 indexed citations
5.
Kovatcheva, Marta, Mark A. Dickson, Mary E. Klein, et al.. (2015). MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget. 6(10). 8226–8243. 102 indexed citations
6.
Havas, Aaron, Mary E. Klein, W.T. Pinkston, et al.. (2013). A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma. Cancer Biology & Therapy. 14(10). 949–961. 20 indexed citations
7.
Harr, Michael W., Xinyang Zhao, Mary E. Klein, et al.. (2011). JAK2 V617F, PRMT5, and GATA-1 Form a Regulatory Loop That Controls Autophagy Via Effects on ATG3 Gene Expression. Blood. 118(21). 2822–2822. 1 indexed citations
8.
Klein, Mary E.. (1988). Hepatitis B virus: Perinatal management. The Journal of Perinatal & Neonatal Nursing. 1(4). 12–23.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026